The artificial cervical intervertebral disc market in South & Central America is expected to grow from US$ 107.89 million in 2022 to US$ 279.70 million by 2028; it is estimated to grow at a CAGR of 17.2% from 2021 to 2028.
Companies in the artificial cervical intervertebral disc market are undertaking many research and development activities to introduce innovative products. The new replacement therapies enable the adoption of advanced technologies, strengthening the procedural outcomes. For instance, in April 2021, UD FDA approved NuVasive Simplify Cervical Artificial Disc for two-level cervical total disc replacement (cTDR).
Additionally, in August 2020, Orthofix Medical Inc., a global medical device company focused on musculoskeletal products and therapies, received the US Food and Drug Administration (US FDA) approval for its M6-C artificial cervical disc for patients suffering from cervical disc degeneration. The M6-C artificial cervical disc, a next-generation artificial disc, is developed to replace an intervertebral disc damaged by cervical disc degeneration, which also restores physiologic motion to the spine. Moreover, in May 2018, Zimmer Biomet received approval from the Japan Ministry of Health, Labour and Welfare (MHLW) for its Mobi-C Cervical Disc for cervical total disc replacement (cTDR). Mobi-C is the first cervical disc prosthesis approved by the US FDA to reconstruct a cervical disc at one and two levels (C3-C7). Such robust developments are likely to reshape the artificial cervical intervertebral disc market during the forecast period.
Based on country, the market is fragmented into Brazil, Argentina, and the Rest of South & Central America. Brazil will hold the largest market share by the end of 2022.
B. Braun Melsugen AG.; Globus Medical, Inc.; Medtronic; NuVasive, Inc.; Orthofix Medical, Inc.; and Zimmer Biomet Holdings, Inc. are the leading companies in the South & Central America artificial cervical intervertebral disc market.
Companies in the artificial cervical intervertebral disc market are undertaking many research and development activities to introduce innovative products. The new replacement therapies enable the adoption of advanced technologies, strengthening the procedural outcomes. For instance, in April 2021, UD FDA approved NuVasive Simplify Cervical Artificial Disc for two-level cervical total disc replacement (cTDR).
Additionally, in August 2020, Orthofix Medical Inc., a global medical device company focused on musculoskeletal products and therapies, received the US Food and Drug Administration (US FDA) approval for its M6-C artificial cervical disc for patients suffering from cervical disc degeneration. The M6-C artificial cervical disc, a next-generation artificial disc, is developed to replace an intervertebral disc damaged by cervical disc degeneration, which also restores physiologic motion to the spine. Moreover, in May 2018, Zimmer Biomet received approval from the Japan Ministry of Health, Labour and Welfare (MHLW) for its Mobi-C Cervical Disc for cervical total disc replacement (cTDR). Mobi-C is the first cervical disc prosthesis approved by the US FDA to reconstruct a cervical disc at one and two levels (C3-C7). Such robust developments are likely to reshape the artificial cervical intervertebral disc market during the forecast period.
South & Central America Artificial Cervical Intervertebral Disc Market Segmentation
The South & Central America artificial cervical intervertebral disc market is analyzed on the basis of material, end user, and country. Based on material, the market has been bifurcated into biopolymer and metal. In 2022, the biopolymer material segment held a larger market share. Based on end user, the market is segmented into hospitals, ambulatory surgical centers, and others. In 2022, the hospitals segment held the largest market share.Based on country, the market is fragmented into Brazil, Argentina, and the Rest of South & Central America. Brazil will hold the largest market share by the end of 2022.
B. Braun Melsugen AG.; Globus Medical, Inc.; Medtronic; NuVasive, Inc.; Orthofix Medical, Inc.; and Zimmer Biomet Holdings, Inc. are the leading companies in the South & Central America artificial cervical intervertebral disc market.
Table of Contents
1. Introduction
3. Research Methodology
4. South & Central America Artificial Cervical Intervertebral Disc Market - Market Landscape
5. South & Central America Artificial Cervical Intervertebral Disc Market - Key Market Dynamics
6. Artificial Cervical Intervertebral Disc Market- South & Central America Analysis
7. South & Central America Artificial Cervical Intervertebral Disc Market Analysis - By Material
8. South & Central America Artificial Cervical Intervertebral Disc Market Analysis - By End User
9. South & Central America Artificial Cervical Intervertebral Disc Market- Country Analysis
10. South & Central America Artificial Cervical Intervertebral Disc Market - Industry Landscape
11. Company Profiles
12. Appendix
List of Figures
List of Tables
Companies Mentioned
- B. Braun Melsugen AG.
- Globus Medical, Inc.
- Medtronic
- NuVasive, Inc.
- Orthofix Medical, Inc.
- Zimmer Biomet Holdings, Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 98 |
| Published | August 2022 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 107.89 Million |
| Forecasted Market Value ( USD | $ 279.7 Million |
| Compound Annual Growth Rate | 17.2% |
| No. of Companies Mentioned | 6 |
